NCT01701557

Brief Summary

Randomized trial to determine if the volume of fluid administration in pediatric patients with DKA impacts the rate of normalization of serum bicarbonate, pH as well as the length of treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable diabetes

Timeline
Completed

Started Nov 2007

Typical duration for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

October 1, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 5, 2012

Completed
Last Updated

October 5, 2012

Status Verified

October 1, 2012

Enrollment Period

2.6 years

First QC Date

October 1, 2012

Last Update Submit

October 3, 2012

Conditions

Keywords

Ketoacidosis Fluids

Outcome Measures

Primary Outcomes (1)

  • time to normalization of bicarbonate and pH

    Laboratory parameters were measured hourly for the first 4 hours, and every 2 to3 hours thereafter until acid-base normalization (pH was above 7.3 or the HCO3 was above 15 mmol/L)

    start of treatment until resolution of DKA an expected average of 12 to 24 hours

Secondary Outcomes (1)

  • the length of treatment

    discharge from the hospital, an expected average of 1-2 days

Study Arms (2)

slow fluid rate

ACTIVE COMPARATOR

bolus 10 ml/kg of NS followed by 1.25 times maintenance rate

Other: slow fluid rate

Fast fluid rate

ACTIVE COMPARATOR

bolus 20 ml/kg of NS followed by 1.5 times maintenance rate

Other: fast fluid rate

Interventions

10 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.25 times maintenance

Also known as: normal saline
slow fluid rate

20 mL/kg of NS intravenous bolus over the first hour followed by ¾ NS with potassium replacement at 1.5 times maintenance

Also known as: normal saline
Fast fluid rate

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • day to 18 years of age
  • type 1 diabetes
  • presence of DKA, as defined by glucose \>250 mg/dl, accumulation of ketone bodies in the blood, and metabolic acidosis (venous pH \< 7.30 or serum bicarbonate \< 15 mmol/L.)

You may not qualify if:

  • requirement for additional fluid resuscitation for hemodynamic instability
  • weight greater than 70 kilograms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Childrens Hospital Colorado

Aurora, Colorado, 80045, United States

Location

Related Publications (1)

  • Bakes K, Haukoos JS, Deakyne SJ, Hopkins E, Easter J, McFann K, Brent A, Rewers A. Effect of Volume of Fluid Resuscitation on Metabolic Normalization in Children Presenting in Diabetic Ketoacidosis: A Randomized Controlled Trial. J Emerg Med. 2016 Apr;50(4):551-9. doi: 10.1016/j.jemermed.2015.12.003. Epub 2016 Jan 25.

MeSH Terms

Conditions

Diabetes Mellitus

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Arleta Rewers, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2012

First Posted

October 5, 2012

Study Start

November 1, 2007

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

October 5, 2012

Record last verified: 2012-10

Locations